Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)

British Journal of Cancer
C ElieGINECO group

Abstract

Epidermal growth factor receptor 1 (EGFR-1) overexpression is usually described as linked with a worse prognosis in a variety of tumours of epithelial origin. However, its role in ovarian cancer is still controversial. The aim of the present study was to analyse the prognostic impact of EGFR-1 in a retrospective series of 93 stage III-IV primary ovarian epithelial tumours. All patients, enrolled in a multicentre GINECO prospective clinical trial, were treated with the same platinum-based combination chemotherapy, and were followed up with a median of 69 months. Epidermal growth factor receptor 1 plasma membrane expression, assessed by immunohistochemistry on paraffin-embedded tissues, was correlated with clinical parameters as well as immunohistochemical expression results of HER-2 (c-erbB-2), BAX, BCL-2, p53 and anti-Ki-67, previously studied in the same series of patients. Positive immunostaining for EGFR-1 was seen in 31 of the 93 analysed cases (33%). No correlation was found between EGFR-1 expression and clinical parameters. No correlation was found between EGFR-1 expression and other biological markers, except for HER-2, which was limit for significance. Indeed, among the EGFR-1-negative cases, 10.3% expressed HER-2, wher...Continue Reading

References

Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G ScambiaS Mancuso
Dec 1, 1990·The British Journal of Surgery·R J SteeleO Eremin
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M E van der BurgJ G Klijn
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K P De JongE G De Vries
May 1, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·I SkirnisdóttirT Seidal
Sep 20, 2001·Journal of the National Cancer Institute· Alper OW G Stetler-Stevenson
Oct 11, 2001·British Journal of Cancer·T G ClarkJ F Smyth
Mar 27, 2002·Audiology & Neuro-otology·Ruth Anne EatockMelissa A Vollrath
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico CappuzzoLucio Crino
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Camilleri-BroëtUNKNOWN GINECO group

❮ Previous
Next ❯

Citations

Oct 13, 2006·Nature Reviews. Cancer·Mukesh K NyatiTheodore S Lawrence
May 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Imran RizviTayyaba Hasan
May 28, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A P Dei Tos, I Ellis
Oct 13, 2006·Gynecologic Oncology·Kathleen M Darcy, Russel J Schilder
Apr 12, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Heini LassusRalf Butzow
Jul 17, 2008·British Journal of Cancer·P de GraeffA G J van der Zee
Jul 9, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Karina Dahl SteffensenAnders Jakobsen
Apr 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C SchindlbeckK Friese
Jan 7, 2009·Current Opinion in Obstetrics & Gynecology·Fiona Collinson, Gordon Jayson
Oct 14, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kirsten M JochumsenOle Mogensen
Jan 9, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Helen J Mackay, Amit M Oza
Apr 19, 2013·Journal of Cancer Research and Clinical Oncology·Linjuan XuZehua Wang
Mar 16, 2012·Future Medicinal Chemistry·Jason A WilkenNita J Maihle
Nov 19, 2013·Cancer Research·Min ZhouZonghai Li
Apr 23, 2009·Molecular Oncology·Henry T LynchAndrew K Godwin
Feb 19, 2008·Experimental and Molecular Pathology·I UberallM Hajdúch
Feb 23, 2008·Biochimica Et Biophysica Acta·Jacqueline M LafkyNita J Maihle

❮ Previous
Next ❯

Software Mentioned

Plus

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.